Cosyntropin vs hGHRH(1-40)OH
Head-to-head comparison of Cosyntropin (Cosyntropin (ACTH 1-24)) and hGHRH(1-40)OH (Human growth hormone-releasing factor (1-40) hydroxyl) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Cosyntropin | hGHRH(1-40)OH |
|---|---|---|
| Category | Pain Management | Growth Hormone |
| Full Name | Cosyntropin (ACTH 1-24) | Human growth hormone-releasing factor (1-40) hydroxyl |
| Molecular Weight | 2933.3 Da | N/A |
| Half-Life | ~10 min | 5-20 minutes |
| Amino Acids | 24 | 40 |
| Typical Dose | 0.25 mg IV/IM diagnostic dose|off-label headache protocols vary | 1-2 mcg/kg |
| Route | IV|IM | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 61 | 85 |
| Research Status | Clinical research | Clinical Research |
Cosyntropin Benefits
- ✓refractory migraine
- ✓anti-inflammatory signaling
- ✓headache rescue research
hGHRH(1-40)OH Benefits
- ✓GH secretion research
- ✓fragment-activity comparison
- ✓receptor binding studies
- ✓axis physiology modeling
Cosyntropin Dosing
0.25 mg IV/IM|1 mg IV/IM
hGHRH(1-40)OH Dosing
1-2 mcg/kg SC or IV in acute research settings|single-bolus GH stimulation protocols|repeated low-dose administration in comparative studies
Cosyntropin Side Effects
- ⚠flushing
- ⚠nausea
hGHRH(1-40)OH Side Effects
- ⚠flushing
- ⚠headache
- ⚠lightheadedness
Research Overview
Cosyntropin
Cosyntropin is not a standard pain drug, but it appears in headache literature because ACTH analogs can help some patients with difficult migraine attacks. The analgesic rationale is partly tied to steroidogenic and anti-inflammatory effects.
hGHRH(1-40)OH
Human GHRF(1-40)OH has been studied to understand how truncation of the native hormone changes biological potency and half-life. It is a common research tool for mapping minimal active sequences within the GHRH family.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.